| 000 | 01726 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515090501.0 | ||
| 264 | 0 | _c20080122 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1873-4995 | ||
| 024 | 7 |
_a10.1016/j.jconrel.2007.08.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamagata, Tetsuo | |
| 245 | 0 | 0 |
_aEffect of excipients on breast cancer resistance protein substrate uptake activity. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cDec 2007 |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aExcipients _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aMitoxantrone _xchemistry |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aKusuhara, Hiroyuki | |
| 700 | 1 | _aMorishita, Mariko | |
| 700 | 1 | _aTakayama, Kozo | |
| 700 | 1 | _aBenameur, Hassan | |
| 700 | 1 | _aSugiyama, Yuichi | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 124 _gno. 1-2 _gp. 1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2007.08.021 _zAvailable from publisher's website |
| 999 |
_c17423015 _d17423015 |
||